noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Avanos Medical Inc.

Statement of Changes in Beneficial Ownership (Form 4)
State of Delaware

Amid Hints of Spring, DNREC Reminds Delawareans of Yard Waste Options,[...]
FEC - Federal Election Commission

FEC to host Corporate PAC Webinar April 21-22 (2026)

Healthcare

Italian Medicines Agency

03/09/2026 | News release | Distributed by Public on 03/09/2026 03:45

Aggiornato il modulo 'Relazione andamento studio'

Il CCNCE ha aggiornato il modulo "Relazione andamento studio".

Rispetto alla versione precedente sono stati rimossi i riferimenti agli studi interventistici farmacologici, in conformità con il Regolamento (UE) 536/2014 e le indicazioni della Commissione europea.

Pubblicato il: 09 marzo 2026

Italian Medicines Agency published this content on March 09, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on March 09, 2026 at 09:45 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format